Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03326323 · ClinicalTrials.gov registry record
Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution
A clinical trial, sponsored by Inova Health Care Services.
- Completed
- Registry status
- 43
- Enrollment target
NCT03326323 is a clinical trial that has completed, run by Inova Health Care Services. The registered enrollment target is 43 participants.
The verdict
NCT03326323 has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This study will help enhance current understanding of the impact of Acute Normovolemic Hemodilution (ANH) administration on transfusion requirements post cardiac surgery, the effect of this procedure on coagulation, and platelet hemostasis, and the amount of chest tube drainage 24 hours post coronary artery bypass graft surgery (CABG) surgery.
Interventions
- PROCEDURE Acute Normovolemic Hemodilution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2018-03-19 |
| Est. Completion | 2019-10-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03326323
The ClinicalTrials.gov registry entry for NCT03326323 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acute Normovolemic Hemodilution is the first listed.
NCT03326323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03326323 about?
NCT03326323 is a clinical study titled "Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution". This study will help enhance current understanding of the impact of Acute Normovolemic Hemodilution (ANH) administration on transfusion requirements post cardiac surgery, the effect of this procedure on coagulation, and platelet hemostasis, and the amount of chest tube drainage 24 hours post coronar...
What is the current status of trial NCT03326323?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2018-03-19. Estimated completion is 2019-10-17.
What interventions are being tested in trial NCT03326323?
The interventions under investigation include: Acute Normovolemic Hemodilution (PROCEDURE).
Who is sponsoring clinical trial NCT03326323?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.